0001209191-19-043330.txt : 20190726 0001209191-19-043330.hdr.sgml : 20190726 20190726161436 ACCESSION NUMBER: 0001209191-19-043330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190724 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS ROBERT T. JR. CENTRAL INDEX KEY: 0001563606 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 19978227 MAIL ADDRESS: STREET 1: INTEGRA LIFESCIENCES CORPORATION STREET 2: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-24 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001563606 DAVIS ROBERT T. JR. 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536 0 1 0 0 CVP,PRES-ORTHO & TISSUE TECH Common Stock 2019-07-24 4 S 0 11234 63.135 D 37272 D Common Stock 2019-07-24 4 M 0 4698 26.865 A 41970 D Common Stock 2019-07-24 4 S 0 4698 63.00 D 37272 D Common Stock 2019-07-24 4 M 0 5052 32.585 A 42324 D Common Stock 2019-07-24 4 S 0 5052 63.00 D 37272 D Non-Qualified Stock Option (right to buy) 26.865 2019-07-24 4 M 0 4698 0.00 D 2023-03-23 Common Stock 4698 1566 D Non-Qualified Stock Option (right to buy) 32.585 2019-07-24 4 M 0 5052 0.00 D 2024-03-14 Common Stock 5052 8736 D The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. This stock option was previously reported as covering 2,710 shares of common stock at an exercise price of $62.10 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/14/2016. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Eric Schwartz; Attorney-in-Fact 2019-07-26